GH Price Target Alert: $135.00. Issued by Canaccord Genuity
Source: KlickAnalytics
2026-02-20 07:04:03 ET
Full story available on KlickAnalytics.com
Guardant Health Inc.
NASDAQ: GH
GH Trading
-2.3% G/L:
$88.75 Last:
622,082 Volume:
$89.50 Open:
GH Latest News
March 10, 2026 08:05:00 am
Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
March 04, 2026 07:00:00 am
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America
GH Stock Data
$13,330,105,573
118,352,583
3.47%
191
N/A
Medical Diagnostics & Screening
Healthcare
US
Palo Alto
